KOR
Global
EU
UK
Contact
Home
About
Solutions
R&D
IR
Media
Request a Demo
Screening for Lung Cancer
Solution
Comparative Performance of 3 Artificial Intelligence Systems for Lung Nodule Characterization in Low-Dose Computed Tomography Screening
Artificial Intelligence–Assisted Lung Nodule Evaluation on Low-Dose Chest CT in Asymptomatic Individuals: A Prospective Randomized Controlled Trial
Negligible impact of perifissural nodules in an AI-first reader workflow from UK lung screening trial
Differentiation of pulmonary tuberculosis from non-tuberculous solid lung lesions using radiomics and clinical-semantic features on contrast-enhanced CT
Leveraging Artificial Intelligence to Transform Thoracic Radiology for Lung Nodules and Lung Cancer - Applications, Challenges, and Future Directions
AI Performance for Nodule Volume Doubling Time in the follow-up of the UKLS Lung Cancer Screening Study Compared to Expert Consensus and Histological Validation
Potential for AI as first reader in lung cancer screening
문의하기
일반 문의
T+82. 2. 571. 7321
F+82. 2. 571. 7324
국내 사업부
T+82. 70. 7711. 6061
Esales@corelinesoft.com
해외 사업부
T+82. 70. 7711. 6064
Eobd@corelinesoft.com
기술지원팀
T+82. 70. 7711. 6063
Esupport@corelinesoft.com
IR 관련 문의
T+82. 2. 336. 7321
Eir@corelinesoft.com
유럽 법인
T+49. 69. 5800. 11870
Ecle@corelinesoft.com
Frankfurter Landstraße 62a, 61440 Oberursel, Germany
북미 법인
T+1. 470. 881. 2747
Eusa@corelinesoft.com
530 Highland Station Dr., STE 2002, Suwanee, GA 30024